Coverage Universe
BSR maintains formal coverage on the development-stage biotechnology companies listed below. Having a company in our coverage universe does not necessarily mean we see them as a good investment. Our opinions on the companies appearing below range from a belief they should be overweight in a diversified biotechnology portfolio to a determination they are not suitable for investment capital. Clicking on the name of the company takes you to brief summary and a link to everything we've published on the company.


Company Ticker First coverage
Aegerion Pharmaceuticals AEGR July 2012
BioMarin Pharmaceuticals BMRN October 2004
Corcept Therapeutics CORT September 2004
Dendreon DNDN February 2001
Dynavax DVAX July 2006
Exelixis EXEL January 2011
ImmunoGen IMGN October 2009
Medivation MDVN January 2011
Oncolytics Biotech ONCY June 2005
GenMark Diagnostics GNMK February 2008
NuPathe PATH March 2011
Raptor Pharmaceuticals RPTP July 2008
Repros Therapeutics RPRX February 2006
Resverlogix TSE:RVX January 2008
Seattle Genetics SGEN June 2002


© 2006-2012 Biotech Stock Research, LLC. Use of this site is governed by the Terms and Conditions.